Publication | Closed Access

Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial

ThrombosisCardiovascular DiseaseHereditary AngioedemaPharmacologyPlacebo-controlled TrialPharmacotherapyAngiologyFast-3 TrialMedicineAtherosclerosis